Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2020
- Schlagwort
-
Phosphorylation
Protein-tyrosine kinase
Entzündung
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bsz:21-dspace-980787
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bittner, Zsófia Ágnes
- Weber, Alexander N. R.
- Universitätsbibliothek Tübingen
Entstanden
- 2022
Ähnliche Objekte (12)
Synthesis of a Bruton’s Tyrosine Kinase Inhibitor
Editorial: Targeting bruton tyrosine kinase
Bruton’s tyrosine kinase (BTK) and matrix metalloproteinase-9 (MMP-9) regulate NLRP3 inflammasome-dependent cytokine and neutrophil extracellular trap responses in primary neutrophils
Role of Bruton’s tyrosine kinase in B cells and malignancies
Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances
Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia
Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis
PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases
Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies
Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
Second-generation inhibitors of Bruton tyrosine kinase
Synthesis of a Bruton’s Tyrosine Kinase Inhibitor
Editorial: Targeting bruton tyrosine kinase
Bruton’s tyrosine kinase (BTK) and matrix metalloproteinase-9 (MMP-9) regulate NLRP3 inflammasome-dependent cytokine and neutrophil extracellular trap responses in primary neutrophils
Role of Bruton’s tyrosine kinase in B cells and malignancies
Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances
Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia
Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis
PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases
Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies
Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
Second-generation inhibitors of Bruton tyrosine kinase
Synthesis of a Bruton’s Tyrosine Kinase Inhibitor
Editorial: Targeting bruton tyrosine kinase
Bruton’s tyrosine kinase (BTK) and matrix metalloproteinase-9 (MMP-9) regulate NLRP3 inflammasome-dependent cytokine and neutrophil extracellular trap responses in primary neutrophils
Role of Bruton’s tyrosine kinase in B cells and malignancies
Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances
Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia
Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis
PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases
Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies
Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease